EE411 Cost-Utility of Nabiximols for the Management of Spasticity Due to Multiple Sclerosis in Switzerland
Autor: | Schwander, B, Dykukha, I, Merinova, M, Akmaz, B |
---|---|
Zdroj: | In Value in Health December 2022 25(12) Supplement:S136-S136 |
Databáze: | ScienceDirect |
Externí odkaz: |